Briefly, the variants were identified - thanks to the researchers in South Africa 🇿🇦 who have been using genomic surveillance quite efficiently. We knew about these two variants as early as April 2022 as cases were slowly increasing in SA just after the omicron wave.
BA.4 and BA.5 are subvariants of Omicron which was the most recent VoC . The rapid spread of omicron across the world has created a large number of subvarinats- each characterised by specific combination of mutations. BA.4 and BA.5 are interesting in many ways.
⚪ Immune Escape
The variant can infect individuals who had immunity against #SARSCoV2 from previous infections or vaccines. It is thought that the L452R mutation in spike could contribute significantly to this.
ESC has details about the mutation clingen.igib.res.in/esc/
⚪ Fusogenicity
BA.4/BA.5 variants seem to apparently have better fusogenixity in experimental laboratory models . Data from @SystemsVirology has been key in this regard biorxiv.org/content/10.110…
🔴 Does this impact everyone the same way ?
Apparently NO.
There seems to be more we dont yet understand on what influences the severity (deaths/hospitalisation) in a region wrt another.
For example, the BA.4/BA.5 wave did not cause much of an issue in South Africa. @rid1tweets has a wonderful comparison 👇
Now what does that mean to containment efforts?
We need to keep in consideration 1. Prior immunity is likely not protective 2. Proportion of at-risk individuals in population 3. Almost cyclical nature of waves of infection- in the past and also expected on future.
🔴 we do have many very effective non- pharmacological interventions at hand
MASKS - good quality (like N95) masks are quite effective in preventing infections. So continued mandates are possibly needed for a longer term, especially for high risk people.
So better and more masks
VENTILATION- even small efforts to improve ventilation could significantly reduce the risk of infections. Places where crowding is unavoidable and ventilation is not effective, air filters could be mandated - as in halls, malls, etc.
🔴 Until we have newer generations of vaccines (which I don't see widely being available across the world due to existing inequities) MASKS and VENTILATION are our best and effective alternatives to keep the infection at bay.
Avoiding infections are indeed important, to avoid associated morbidity
⚪ The infection might be apparently mild, but with long term insult to your body.
🔴 What about India 🇮🇳?
BA.4 /BA.5 has been identified in India and going by data in public domain, increasing in many states.
An effective, consistent genomic surveillance system can uncover trends . We could learn a lot from around the world and within the country.
🔴 There is little / no data in public domain from many regions in India having an ongoing active wave of infection. So assessment of what are driving these waves is not possible at the moment.
A lot of discussion about B.1.640.2 reported from Southern France 🇫🇷 and a preprint on the variant medrxiv.org/content/10.110…
This 🧵is to summarize what we know. 👇
🔴14 changes including N501Y and E484K, & 9 deletions in Spike
🔵B.1.640 (now renamed B.1.640.1) had been in the @WHO watchlist for quite some time (Nov 2021)
🔵Index case seemingly was from Cameroon (doesn't mean it originated there)
🔴Many of the mutations are shared with VoCs
🟢Though predates omicron, sequences have not grown rapidly
🟢 Mutation specific qPCR assays can screen and differentiate from Delta and Omicron
🔴We don't know whether the increasing cases in South France 🇫🇷 are associated with the new variant
🔴Transmissibility or Virulence : What should really worry us ?
Since these two have been widely discussed, given #omicron is around. A short explainer 👇.
3 plots below - from ~2x of Rt value and 1/2 of hospitalization rates (less virulent) to basal value (~ Delta wave)
Rt is the effective reproductive no.
One could clearly see why 2x Rt would create a sharper and ⏫rate of hospitalizations.
For a less virulent and highly transmissible variant, assuming 1/2x hospitalization rate, this would still create a significant wave of hospitalizations.
A much detailed mathematical basis to this was discussed in the past by @AdamJKucharski
SARS-CoV-2 Variants and RT-PCR
Can RT-PCR Detect Omicron ?
A short thread on the topic. 👇
RT-PCR is a sensitive molecular method widely used for the detection of SARS-CoV-2 in biological samples. This is based on the principle that short pieces of DNA (aka primers) can specifically target DNA/RNA and amplify them using a polymerase protein
Typically COVID-19 RT-PCR kits use 2 or more sets of primers which target the virus nucleic acid at 2 or more genes/sites in the genome. This is to improve the specificity of the detection. Combinations between N, E, RdRP and S genes are typically used.
What do we know about the B.1.1.529 variant of SARS-CoV-2 with a very large number of mutations
An updated thread on emerging evidence.
B.1.1.529 is a newly designated variant of SARS-CoV-2 github.com/cov-lineages/p…
This would not have been possible without the exemplary work of researchers in Africa who have sequenced and deposited the genomes in public domain which forms the basis of this variant designation.
Real-world data on effectiveness of BBV152 / Covaxin whole inactivated #COVID19 vaccine against symptomatic infection
👥Healthcare Workers at @aiims_newdelhi
🗓 Coincided with the 2nd wave in #Delhi majorly driven by VoCs thelancet.com/journals/lanin…
Adjusted effectiveness of BBV152 against symptomatic COVID-19 after 2 doses adm at least
🔸️14d before testing was 50% (95% CI 33–62; p<0·0001).
🔸️28d before testing was 46% (95% CI 22–62)
🔸️after excluding previous COVID19 cases, 14d before testing was 47% (95% CI 29–61)
In summary
🔸️Vaccine effectiveness requires at least 2 doses and 14 days after 2nd dose
What this means for #PublicHealth
🔸️ Underscores the need for completing vaccine schedule of 2doses
🔸️ Continued non-pharmacological measures in the face of a wave of infections